Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 3/20 | 0.59 |
| ▸ | HTR2C | P28335 | 3/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | HTR4 | Q13639 | 2/20 | 0.36 |
| ▸ | HTR3A | P46098 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
| ▸ | HTR7 | P34969 | 5/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31486922 | 0.85 | HTR2A (0.44) | HTR2AHTR2C | |
| SCHEMBL31486982 | 0.84 | HTR2A (0.42) | HTR2AHTR2CHTTHTR4HTR3A | |
| SCHEMBL31486796 | 0.82 | HTR2A (0.66) | HTR2AHTR2CHTTPOLB | |
| SCHEMBL31486896 | 0.77 | HTT (0.43) | HTR2AHTR2CHTTHTR3APOLB | |
| SCHEMBL6711010 | 0.74 | HTR2A (1.00) | HTR2AHTR2CHTTKDM4E | |
| SCHEMBL31486876 | 0.71 | KMT2A (0.40) | — | |
| SCHEMBL31487253 | 0.70 | HTR3A (0.49) | HTR4HTR3A | |
| SCHEMBL7321713 | 0.69 | HTR2A (0.53) | HTR2AHTR2CHTTKDM4EIDO1 | |
| SCHEMBL614943 | 0.69 | HTR2A (0.53) | HTR2AHTR2C | |
| SCHEMBL31486655 | 0.68 | HTT (0.35) | HTR2AHTR2CHTTHTR3APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025077825-A1 | METHODS AND COMPOSITIONS FOR TREATING CARDIO-PULMONARY DISORDERS | FAUNA BIO INCORPORATED (US) | 2025-04-17 | — | — | WO | disclosed |